These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34038468)

  • 21. Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period.
    Mencarini J; Mantengoli E; Tofani L; Riccobono E; Fornaini R; Bartalesi F; Corti G; Farese A; Pecile P; Boni L; Rossolini GM; Bartoloni A
    Infection; 2018 Aug; 46(4):469-476. PubMed ID: 29654496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
    Iatta R; Caggiano G; Cuna T; Montagna MT
    J Chemother; 2011 Apr; 23(2):92-6. PubMed ID: 21571625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and therapeutic aspects of candidemia: a five year single centre study.
    Bassetti M; Merelli M; Ansaldi F; de Florentiis D; Sartor A; Scarparo C; Callegari A; Righi E
    PLoS One; 2015; 10(5):e0127534. PubMed ID: 26010361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013.
    Montagna MT; Lovero G; Borghi E; Amato G; Andreoni S; Campion L; Lo Cascio G; Lombardi G; Luzzaro F; Manso E; Mussap M; Pecile P; Perin S; Tangorra E; Tronci M; Iatta R; Morace G
    Eur Rev Med Pharmacol Sci; 2014; 18(5):661-74. PubMed ID: 24668706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence, characteristics and outcome of ICU-acquired candidemia in India.
    Chakrabarti A; Sood P; Rudramurthy SM; Chen S; Kaur H; Capoor M; Chhina D; Rao R; Eshwara VK; Xess I; Kindo AJ; Umabala P; Savio J; Patel A; Ray U; Mohan S; Iyer R; Chander J; Arora A; Sardana R; Roy I; Appalaraju B; Sharma A; Shetty A; Khanna N; Marak R; Biswas S; Das S; Harish BN; Joshi S; Mendiratta D
    Intensive Care Med; 2015 Feb; 41(2):285-95. PubMed ID: 25510301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.
    Bassetti M; Merelli M; Righi E; Diaz-Martin A; Rosello EM; Luzzati R; Parra A; Trecarichi EM; Sanguinetti M; Posteraro B; Garnacho-Montero J; Sartor A; Rello J; Tumbarello M
    J Clin Microbiol; 2013 Dec; 51(12):4167-72. PubMed ID: 24108614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
    Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
    PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.
    Toda M; Williams SR; Berkow EL; Farley MM; Harrison LH; Bonner L; Marceaux KM; Hollick R; Zhang AY; Schaffner W; Lockhart SR; Jackson BR; Vallabhaneni S
    MMWR Surveill Summ; 2019 Sep; 68(8):1-15. PubMed ID: 31557145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
    Bassetti M; Taramasso L; Nicco E; Molinari MP; Mussap M; Viscoli C
    PLoS One; 2011; 6(9):e24198. PubMed ID: 21935385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Alarming Rise of Candidemia Caused by Non-Albicans Candida Species in Intensive Care Unit in Mymensingh, Bangladesh.
    Sathi FA; Alam MM; Haque N; Khan MJA; Mamun AA; Hossain T; Chowdhury CS; Islam MN; Ferdaus SJ; Sultana M
    Mymensingh Med J; 2024 Jul; 33(3):671-676. PubMed ID: 38944705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
    Doğan Ö; Yeşilkaya A; Menekşe Ş; Güler Ö; Karakoç Ç; Çınar G; Kapmaz M; Aydın M; Keske Ş; Şahin S; Hacıseyitoğlu D; Yalçın D; Tekin S; Ataç N; Albayrak Ö; Aksu ED; Can F; Ergönül Ö
    Int J Antimicrob Agents; 2020 Jul; 56(1):105992. PubMed ID: 32335275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for candidemia with non-albicans Candida spp. in intensive care unit patients with end-stage renal disease on chronic hemodialysis.
    Serefhanoglu K; Timurkaynak F; Can F; Cagir U; Arslan H; Ozdemir FN
    J Formos Med Assoc; 2012 Jun; 111(6):325-32. PubMed ID: 22748623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors associated with fluconazole resistance in Candida parapsilosis candidemia: A case-case study.
    Atalay S; Çağlayan D; Arkalı E; Sönmez U; Şamlıoğlu P
    Mycoses; 2024 Mar; 67(3):e13717. PubMed ID: 38544313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species distribution and antifungal susceptibilities of bloodstream
    Brescini L; Mazzanti S; Orsetti E; Morroni G; Masucci A; Pocognoli A; Barchiesi F
    J Chemother; 2020 Sep; 32(5):244-250. PubMed ID: 32580685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Change in species distribution and antifungal susceptibility of candidemias in an intensive care unit of a university hospital (10-year experience).
    Mete B; Zerdali EY; Aygun G; Saltoglu N; Balkan II; Karaali R; Kaya SY; Karaismailoglu B; Kaya A; Urkmez S; Can G; Tabak F; Ozturk R
    Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):325-333. PubMed ID: 32935158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology, species, antifungal resistance and outcome of candidemia in a university hospital in Buenos Aires, Argentina for 16 years].
    Tiraboschi IN; Pozzi NC; Farías L; García S; Fernández NB
    Rev Chilena Infectol; 2017 Oct; 34(5):431-440. PubMed ID: 29488584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: A six-year retrospective study.
    Medeiros MAP; Melo APV; Bento AO; Souza LBFC; Neto FAB; Garcia JB; Zuza-Alves DL; Francisco EC; Melo ASA; Chaves GM
    PLoS One; 2019; 14(8):e0221033. PubMed ID: 31437188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.
    Li Y; Du M; Chen LA; Liu Y; Liang Z
    Mycopathologia; 2016 Aug; 181(7-8):485-95. PubMed ID: 26994763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.